645 SUMMER STREET, BOSTON, MA
Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook, Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
Annual Report to Security Holders
Financial Results, Press Release
Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
Appoints Christopher D. Brown to its Board of Directors
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Specialized Disclosure Report